GB0704014D0 - New use of glutaminyl cyclase inhibitors - Google Patents

New use of glutaminyl cyclase inhibitors

Info

Publication number
GB0704014D0
GB0704014D0 GBGB0704014.0A GB0704014A GB0704014D0 GB 0704014 D0 GB0704014 D0 GB 0704014D0 GB 0704014 A GB0704014 A GB 0704014A GB 0704014 D0 GB0704014 D0 GB 0704014D0
Authority
GB
United Kingdom
Prior art keywords
new use
glutaminyl cyclase
cyclase inhibitors
inhibitors
glutaminyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0704014.0A
Other versions
GB2447017A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivoryon Therapeutics AG
Original Assignee
Probiodrug AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiodrug AG filed Critical Probiodrug AG
Priority to GB0704014A priority Critical patent/GB2447017A/en
Publication of GB0704014D0 publication Critical patent/GB0704014D0/en
Publication of GB2447017A publication Critical patent/GB2447017A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
GB0704014A 2007-03-01 2007-03-01 New use for inhibitors of glutaminyl peptide cyclotransferinase Withdrawn GB2447017A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0704014A GB2447017A (en) 2007-03-01 2007-03-01 New use for inhibitors of glutaminyl peptide cyclotransferinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0704014A GB2447017A (en) 2007-03-01 2007-03-01 New use for inhibitors of glutaminyl peptide cyclotransferinase

Publications (2)

Publication Number Publication Date
GB0704014D0 true GB0704014D0 (en) 2007-04-11
GB2447017A GB2447017A (en) 2008-09-03

Family

ID=37965769

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0704014A Withdrawn GB2447017A (en) 2007-03-01 2007-03-01 New use for inhibitors of glutaminyl peptide cyclotransferinase

Country Status (1)

Country Link
GB (1) GB2447017A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4335509A3 (en) 2017-05-26 2024-06-05 Ltd "Valenta-Intellekt" Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004026289D1 (en) * 2003-05-05 2010-05-12 Probiodrug Ag Glutaminyl INHIBITORS
KR101121882B1 (en) * 2003-10-15 2012-04-12 프로비오드룩 아게 Use of effectors of glutaminyl and glutamate cyclases
AU2004290499C1 (en) * 2003-11-03 2011-02-24 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
AU2005210004B2 (en) * 2004-02-05 2010-10-28 Probiodrug Ag Novel inhibitors of glutaminyl cyclase

Also Published As

Publication number Publication date
GB2447017A (en) 2008-09-03

Similar Documents

Publication Publication Date Title
IL200315A0 (en) New use of glutaminyl cyclase inhibitors
HRP20192282T8 (en) Tfpi inhibitors and methods of use
PT2397142T (en) Use of dpp iv inhibitors
IL197090A (en) Methods for the identification of inhibitors of glutaminyl cyclase variants
TWI372623B (en) Inhibitors of 11β-hydroxysteroid dehydrogenase
ZA201201366B (en) Heterocycic derivatives as inhibitors of glutaminyl cyclase
EP2192838A4 (en) Heterocyclic inhibitors of necroptosis
HK1172326A1 (en) Compounds and compositions and methods of use
IL213596A0 (en) Heterocyclic compounds and methods of use
HK1146792A1 (en) Parp inhibitor compounds, compositions and methods of use parp
GB0722216D0 (en) Use of crth2 antagonist compounds
GB0722203D0 (en) Use of CRTH2 antagonist compounds
EP2084139A4 (en) Oxazolidinium compounds and use as hydrate inhibitors
DK2160389T3 (en) Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors
DK2160380T3 (en) Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
HK1137756A1 (en) Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors hif--4-
EP2242501A4 (en) Therapeutic inhibitors of pai-1 function methods of their use
EP2242367A4 (en) Rel inhibitors and methods of use thereof
HK1167406A1 (en) Pyrazolone-derivatives and their use as pd4 inhibitors pd4
GB0704014D0 (en) New use of glutaminyl cyclase inhibitors
GB0703514D0 (en) Use of riboflavin
ZA201003156B (en) Use of liquefied-gas compositions
GB0623958D0 (en) Novel inhibitors of glutaminyl cyclase
GB0622246D0 (en) Novel inhibitors of glutaminyl cyclase
GB0622245D0 (en) Novel inhibitors of glutaminyl cyclase

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)